Navigation Links
Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications
Date:6/10/2009

WILMINGTON, Del., June 10 /PRNewswire/ -- Today, the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee conducted a review of the efficacy and safety of supplemental new drug applications (sNDAs) for SEROQUEL (quetiapine fumarate) tablets proposed for the acute treatment of schizophrenia in adolescents (13-17 years of age), and the acute treatment of bipolar mania in children and adolescents (10-17 years of age).

    The Advisory Committee voted as follows:

    Questions to the Advisory Committee              Yes    No   Abstain
    1. Has Seroquel been shown to be effective
       for the treatment of schizophrenia in
       pediatric patients ages 13-17?                 17     1      0
    2. Has Seroquel been shown to be acceptably
       safe for the treatment of schizophrenia in
       pediatric patients ages 13-17?                 16     0      2
    3. Has Seroquel been shown to be effective
       for the treatment of bipolar mania in
       pediatric patients ages 10-17?                 17     0      1
    4. Has Seroquel been shown to be acceptably
       safe for the treatment of bipolar mania
       in pediatric patients ages 10-17?              13     0      5

Howard Hutchinson, M.D., Chief Medical Officer of AstraZeneca, said: "We are pleased that the committee found SEROQUEL to be effective and acceptably safe for treating adolescents with schizophrenia and children and adolescents with bipolar mania, and we look forward to having further discussions with the FDA regarding the sNDAs."

The current approved indications for SEROQUEL are unchanged. SEROQUEL is not approved for use in patients under the age of 18 in any country.

The FDA frequently convenes advisory committee meetings to obtain independent expert guidance and recommendations on clinical matters. While the FDA is not required to follow this guidance, the agency
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions
2. In Texas, Favorable Regulations for Physicians May Backfire in Light of Market Downturn
3. Early results favorable for 5-day radiation treatment of early stage prostate cancer
4. Cynosure Obtains Favorable Markman Rulings in Patent Infringement Case Against CoolTouch
5. ECO2 Plastics, Inc. Receives Favorable FDA Opinion Letter Approving the Use of Its Recycled Plastic Flake in Food Packaging Applications
6. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide
7. WorldHeart Receives Favorable Decision to Continue NASDAQ Listing
8. Non-parental care of infants tied to unfavorable feeding practices
9. Senetek PLC Resolves Dispute With Marketer of Pyratine-6(TM) on Most Favorable Terms
10. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
11. Memry Corporation Plans to Appeal Unfavorable Court Result
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... ... Shelled Out, a new household invention that makes shelling eggs an exact science. ... 2020,” says Scott Cooper, CEO and Creative Director of World Patent Marketing. “With ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... to co-host “The Soul of Philanthropy Reframed and Exhibited,” a photographic and narrative ... Welton Street, in Denver’s historic Five Points neighborhood. , Denver is one of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Autism is ... 68 children currently affected with the disorder. For these families, identifying and paying ... recovery is extremely daunting. That’s where Talk About Curing Autism (TACA), a national ...
(Date:7/28/2015)... , ... July 16, 2015 (PRWEB) July 28, ... ... in Miami, FL, that specializes in providing Health insurance quotes to its clients, ... clients compare auto insurance rates that best suits their specific needs. , ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Aziz Ahmad recently gave a talk on ... noon to 1 p.m. Tuesday, June 23, at the Gulf Coast Regional Medical Center ... is board-certified in colorectal surgery and has more than 35 years of experience in ...
Breaking Medicine News(10 mins):Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:Nations Insurance Solutions Announces Auto, Motorcycle, and Commercial Business Insurance Quotes. 2Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2
... ... service used by medical practices to deliver health information to patients leads to reduced ... ... Vivacare has recently enhanced its Web-based patient education service, providing medical practices with ...
... July 7 Frost & Sullivan has conferred two ... The "2008 Frost & Sullivan European Pharmaceutical Water & ... for its successful strategies that have enabled it to ... water and wastewater solution providers for the pharmaceutical industry ...
... during a Caesarean section helps manage pain after the ... Cochrane Researchers. The researchers recommend local anaesthetics as part ... provided that consideration is given to the cost. ... the growing number of women giving birth by Caesarean ...
... Sonitus Medical, Inc., a medical device company developing ... transmit sound via the teeth, today announced the acceptance ... its SoundBite(TM) hearing system. The article, featuring a preliminary ... published in an upcoming issue of the esteemed ...
... CHICAGO, July 7 The economic crisis is forcing many ... and scaling down information technology (IT) projects, according to a ... systems. While progress has been made and incentives to ... legislation, many hospitals still have a long way to go. ...
... showed high levels of protection against human papillomavirus , ... (HPV) vaccine is highly effective at preventing precancerous cervical ... study shows. , The researchers also found that the ... cancer-causing HPV types closely related to HPV-16/18, most notably ...
Cached Medicine News:Health News:Vivacare Patient Education Service Enhancements Save Medical Practices Time and Money and Improve Patient Satisfaction 2Health News:Vivacare Patient Education Service Enhancements Save Medical Practices Time and Money and Improve Patient Satisfaction 3Health News:Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies 2Health News:Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies 3Health News:Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies 4Health News:Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies 5Health News:SoundBite(TM) Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology & Neurotology Journal 2Health News:SoundBite(TM) Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology & Neurotology Journal 3Health News:Economy Forces Most Wired Hospitals to Look Closely at IT Spending 2Health News:Economy Forces Most Wired Hospitals to Look Closely at IT Spending 3Health News:New Evidence Supports HPV Vaccine 2
(Date:7/28/2015)... 28, 2015  Zipnosis, the first virtual care solution to ... launch their own branded virtual care service line, announced an ... CareNow is currently in use. ... As health ... recognize the value of providing their own branded online care ...
(Date:7/28/2015)... BAUDETTE, Minn. , July 28, 2015 ... that the Company plans to release its second quarter ... 2015, before the opening of the U.S. financial markets. ... Investor Relations section of the Company,s website, www.anipharmaceuticals.com ... and Chief Executive Officer, and Charlotte C. Arnold ...
(Date:7/28/2015)... July 28, 2015 Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and marketing ... an underwritten public offering of 6,666,667 shares of ... of $11.25 per share. The gross proceeds to ... approximately $75 million, before deducting the underwriting discounts ...
Breaking Medicine Technology:Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results 2Egalet Announces Pricing of Public Offering of Common Stock 2Egalet Announces Pricing of Public Offering of Common Stock 3Egalet Announces Pricing of Public Offering of Common Stock 4
... Calif., April 10, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences Incorporated ... and preclinical pipeline, including its Hsp90,inhibitor, epothilone and ... of the American Association for Cancer Research,(AACR), being ... Poster presentations on Kosan's programs are as follows. ...
... -- ImClone,Systems Incorporated and Bristol-Myers Squibb Company ... ERBITUX(R) (Cetuximab) plus,gemcitabine (a chemotherapy) in patients ... did not meet its,primary endpoint of improving ... Oncology Group (SWOG), a cancer,center network sponsored ...
Cached Medicine Technology:Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 2Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 3Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 2Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 3Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 4Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 5Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 6Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 7Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 8Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 9
... The Mini-Sub cell GT system, ... and mini-gel caster, is used for ... acids in mini format agarose gels. ... 7 x 7 cm UV-transparent gel ...
... cell GT system, with 15 x 7 ... for submerged horizontal gel electrophoresis of nucleic ... system includes an electrophoresis cell, 15 x ... mini-gel caster, and two 1.5 mm fixed-height ...
... future generations. Most gels can be dried by ... our gel dryer, covering them with wet semi-permeable ... hold the cellophane flat. Tut's Tombs also produce ... area somewhat larger than the gel to be ...
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
Medicine Products: